Roderick J Clifton-Bligh Selected Research

Papillary Thyroid Cancer

1/2023	Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.
1/2022	Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
1/2021	Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer.
11/2016	Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
1/2016	TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.
8/2015	Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
12/2013	MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
12/2013	Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinoma.
12/2012	Papillary thyroid carcinoma in pregnancy: a variant of the disease?
9/2012	Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roderick J Clifton-Bligh Research Topics

Disease

32	Neoplasms (Cancer) 04/2024 - 04/2006
16	Paraganglioma (Paragangliomas) 04/2024 - 06/2010
13	Pheochromocytoma 04/2024 - 06/2010
10	Papillary Thyroid Cancer 01/2023 - 09/2012
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 02/2014
7	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 03/2008
6	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 08/2015
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2020 - 09/2012
4	Neoplasm Metastasis (Metastasis) 06/2019 - 04/2009
4	Vitamin D Deficiency 12/2015 - 02/2013
3	Hypophosphatemia 06/2023 - 08/2006
3	Hypothyroidism 08/2022 - 01/2021
3	Melanoma (Melanoma, Malignant) 01/2022 - 02/2018
3	Atrophy 12/2015 - 02/2014
2	Leiomyomatosis 01/2023 - 05/2016
2	Congenital Hypothyroidism (Cretinism) 01/2023 - 08/2022
2	Leiomyoma (Uterine Fibroids) 01/2023 - 05/2016
2	Hyperplasia 08/2022 - 01/2018
2	Thyrotoxicosis 01/2022 - 01/2021
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2021 - 01/2019
2	Goiter 08/2015 - 12/2013
2	Adenoma (Adenomas) 04/2014 - 04/2009
2	Insulin Resistance 02/2014 - 02/2013
2	Oncogenic osteomalacia 12/2013 - 02/2013
2	Muscle Weakness 02/2013 - 02/2013
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2012 - 06/2010
2	Adrenocortical Carcinoma 01/2011 - 12/2009
2	Follicular Adenocarcinoma 04/2006 - 01/2006
1	medullary Thyroid cancer 12/2023
1	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 06/2023
1	Hypocalcemia 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Oncogene Addiction 01/2023
1	Circulating Neoplastic Cells 07/2021
1	Chondrosarcoma 01/2021
1	Acromegaly 01/2021
1	Adenocarcinoma 01/2021
1	Lymphatic Metastasis 10/2020
1	Necrosis 10/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 10/2020
1	Hypoparathyroidism 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019
1	Primitive Neuroectodermal Tumors (PNET) 06/2019
1	Hypercalcemia (Milk Alkali Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

19	Succinate Dehydrogenase (Fumarate Reductase)IBA 04/2024 - 06/2010
7	Proteins (Proteins, Gene)FDA Link 11/2019 - 04/2006
6	MicroRNAs (MicroRNA)IBA 07/2021 - 04/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 04/2006
4	Phosphotransferases (Kinase)IBA 04/2024 - 01/2023
4	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2023 - 02/2013
4	Succinic Acid (Succinate)IBA 01/2023 - 03/2017
3	Phosphates (Orthophosphate)IBA 06/2023 - 08/2006
3	FumaratesIBA 01/2023 - 03/2017
3	Immune Checkpoint InhibitorsIBA 01/2022 - 02/2018
3	IodineIBA 01/2022 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	Hormones (Hormone)IBA 01/2019 - 08/2009
3	Vitamin D FDA LinkGeneric 12/2015 - 02/2013
3	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2015 - 02/2014
2	Amino Acids FDA Link 01/2023 - 04/2006
2	polyalanineIBA 01/2023 - 09/2012
2	EnzymesIBA 01/2023 - 01/2021
2	Fumarate Hydratase (Fumarase)IBA 01/2023 - 05/2016
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2022 - 01/2021
2	ProlactinIBA 01/2021 - 04/2014
2	Insulin (Novolin)FDA Link 11/2019 - 02/2013
2	CalciumIBA 01/2019 - 01/2018
2	ParaffinIBA 05/2016 - 09/2012
2	Formaldehyde (Formol)FDA Link 05/2016 - 09/2012
2	somatostatin receptor 2IBA 03/2015 - 12/2013
2	Fibroblast Growth Factor-23IBA 12/2013 - 02/2013
2	Messenger RNA (mRNA)IBA 04/2009 - 03/2008
2	PPAR gammaIBA 04/2006 - 01/2006
1	selpercatinibIBA 04/2024
1	Nerve Growth Factors (Neurotrophins)IBA 01/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	CarbonIBA 01/2023
1	Proline (L-Proline)FDA Link 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2022
1	dimemorfan (AT 17)IBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Circulating Tumor DNAIBA 07/2021
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2020
1	Parathyroid Hormone (Parathormone)IBA 01/2020
1	AutoantibodiesIBA 11/2019
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 11/2019
1	ChromatinIBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	sodium-iodide symporter (sodium iodide symporter)IBA 01/2018

Therapy/Procedure

7	Therapeutics 04/2024 - 11/2008
4	Thyroidectomy 01/2023 - 12/2013
3	Immunotherapy 01/2022 - 11/2019
1	Hypophysectomy 08/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021